111 related articles for article (PubMed ID: 35356841)
21. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
22. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
23. Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases.
Pirooznia N; Hasannia S; Lotfi AS; Ghanei M
J Nanobiotechnology; 2012 May; 10():20. PubMed ID: 22607686
[TBL] [Abstract][Full Text] [Related]
24. Preparation of Poly[lactic-co-glycolic] Acid Nanospheres and Its Role in Hepatoma Cells.
Shi Z; Li J; Liang H; Hu H; Jiang H
J Nanosci Nanotechnol; 2021 Feb; 21(2):977-986. PubMed ID: 33183433
[TBL] [Abstract][Full Text] [Related]
25. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
27. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
28. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.
Turk CT; Oz UC; Serim TM; Hascicek C
AAPS PharmSciTech; 2014 Feb; 15(1):161-76. PubMed ID: 24222270
[TBL] [Abstract][Full Text] [Related]
29. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
[TBL] [Abstract][Full Text] [Related]
30. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
31. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity.
Yan F; Zhang C; Zheng Y; Mei L; Tang L; Song C; Sun H; Huang L
Nanomedicine; 2010 Feb; 6(1):170-8. PubMed ID: 19447200
[TBL] [Abstract][Full Text] [Related]
32. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
Tahara K; Yamamoto H; Hirashima N; Kawashima Y
Eur J Pharm Biopharm; 2010 Mar; 74(3):421-6. PubMed ID: 20034563
[TBL] [Abstract][Full Text] [Related]
33. Co-delivery of cisplatin and siRNA through hybrid nanocarrier platform for masking resistance to chemotherapy in lung cancer.
Patel V; Lalani R; Vhora I; Bardoliwala D; Patel A; Ghosh S; Misra A
Drug Deliv Transl Res; 2021 Oct; 11(5):2052-2071. PubMed ID: 33174096
[TBL] [Abstract][Full Text] [Related]
34. Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles.
Da Silva CG; Camps MGM; Li TMWY; Zerrillo L; Löwik CW; Ossendorp F; Cruz LJ
Theranostics; 2019; 9(22):6485-6500. PubMed ID: 31588231
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
[TBL] [Abstract][Full Text] [Related]
36. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles.
Shi L; Wang X; Zhao F; Luan H; Tu Q; Huang Z; Wang H; Wang H
Int J Nanomedicine; 2013; 8():2669-76. PubMed ID: 23926429
[TBL] [Abstract][Full Text] [Related]
37. Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model.
Ali H; Kalashnikova I; White MA; Sherman M; Rytting E
Int J Pharm; 2013 Sep; 454(1):149-57. PubMed ID: 23850397
[TBL] [Abstract][Full Text] [Related]
38. Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation.
Frede A; Neuhaus B; Knuschke T; Wadwa M; Kollenda S; Klopfleisch R; Hansen W; Buer J; Bruder D; Epple M; Westendorf AM
Nanomedicine; 2017 Nov; 13(8):2395-2403. PubMed ID: 28800875
[TBL] [Abstract][Full Text] [Related]
39. Potential use for chronic pain: Poly(Ethylene Glycol)-Poly(Lactic-Co-Glycolic Acid) nanoparticles enhance the effects of Cannabis-Based terpenes on calcium influx in TRPV1-Expressing cells.
El-Hammadi MM; Small-Howard AL; Jansen C; Fernández-Arévalo M; Turner H; Martín-Banderas L
Int J Pharm; 2022 Mar; 616():121524. PubMed ID: 35104595
[TBL] [Abstract][Full Text] [Related]
40. Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo.
Das J; Das S; Paul A; Samadder A; Bhattacharyya SS; Khuda-Bukhsh AR
Toxicol Lett; 2014 Mar; 225(3):454-66. PubMed ID: 24440344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
